Corriente Advisors as of March 31, 2020
Portfolio Holdings for Corriente Advisors
Corriente Advisors holds 11 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc Cl A | 29.6 | $27M | 190k | 144.34 | |
| Maxar Technologies | 19.5 | $18M | 1.7M | 10.68 | |
| Aptose Biosciences | 18.7 | $17M | 2.9M | 5.94 | |
| Cue Biopharma (CUE) | 12.6 | $12M | 820k | 14.19 | |
| Grayscale Bitcoin Ord (GBTC) | 4.5 | $4.2M | 590k | 7.12 | |
| Pieris Pharmaceuticals | 4.4 | $4.1M | 1.8M | 2.28 | |
| Epizyme | 3.9 | $3.6M | 230k | 15.51 | |
| Schrodinger (SDGR) | 2.8 | $2.6M | 60k | 43.12 | |
| Bellus Health | 1.6 | $1.5M | 149k | 9.98 | |
| Sunesis Pharmaceuticals Inc Ne | 1.4 | $1.3M | 3.0M | 0.41 | |
| Tesla Motors (TSLA) | 1.1 | $1.0M | 2.0k | 524.00 |
